PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26289409-0	2016	Pharmacogenetic Study on the Impact of Rivastigmine Concerning Genetic Variants of A2M and IL-6 Genes on Iranian Alzheimer"s Patients.	Rivastigmine	39-51	interleukin 6	Homo sapiens	91-95	
23871825-6	2013	Depending on the treatment received, a distinct inflammatory and oxidative stress profile was observed: in Rivastigmine-treated group, IL6 levels were 47% lower than the average value of the remaining AD patients; homocysteine and glutathione reductase were statistically unchanged in the Rivastigmine and Donepezil-Memantine, respectively Donepezil group.	Rivastigmine	107-119	interleukin 6	Homo sapiens	135-138	
23469045-5	2013	Rivastigmine (1 mg/kg) also reduced myeloperoxidase activity and IL-6 by >60%, and the infiltration of CD11b expressing cells by 80%.	Rivastigmine	0-12	interleukin 6	Homo sapiens	65-69